{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T05:06:56Z","timestamp":1731388016207,"version":"3.28.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,11]]},"DOI":"10.7759\/cureus.73424","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T11:09:43Z","timestamp":1731323383000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and Characteristics of Dyslipidemia in a Hospital in Madagascar"],"prefix":"10.7759","author":[{"given":"Rova Malala Fandresena","family":"Randrianarisoa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abderemane","family":"Abdoul-Kader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirantosoa Fabiola","family":"Ravelonjatovo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narindrarimanana Avisoa","family":"Randriamihangy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59497","article-title":"Racial and socioeconomic determinants of cardiovascular health: a comprehensive review","volume":"16","author":"Borkowski P","year":"2024","unstructured":"Borkowski P, Borkowska N, Mangeshkar S, Adal BH, Singh N. Racial and socioeconomic determinants of cardiovascular health: a comprehensive review. Cureus. 2024, 16:e59497. 10.7759\/cureus.59497","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.4260","article-title":"Prevalence of the metabolic syndrome in the United States, 2003-2012","volume":"313","author":"Aguilar M","year":"2015","unstructured":"Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015, 313:1973-4. 10.1001\/jama.2015.4260","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.03.014","article-title":"Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries","volume":"285","author":"De Backer G","year":"2019","unstructured":"De Backer G, Jankowski P, Kotseva K, et al.. Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries. Atherosclerosis. 2019, 285:135-46. 10.1016\/j.atherosclerosis.2019.03.014","journal-title":"Atherosclerosis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.06.046","article-title":"Impact of lipids on cardiovascular health: JACC health promotion series","volume":"72","author":"Ference BA","year":"2018","unstructured":"Ference BA, Graham I, Tokgozoglu L, Catapano AL. Impact of lipids on cardiovascular health: JACC health promotion series. J Am Coll Cardiol. 2018, 72:1141-56. 10.1016\/j.jacc.2018.06.046","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00541-4","article-title":"Global epidemiology of dyslipidaemias","volume":"18","author":"Pirillo A","year":"2021","unstructured":"Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol. 2021, 18:689-700. 10.1038\/s41569-021-00541-4","journal-title":"Nat Rev Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2016.08.015","article-title":"Burden and risk factors of dyslipidemia-results from a STEPS survey in Punjab India","volume":"11 Suppl 1","author":"Tripathy JP","year":"2017","unstructured":"Tripathy JP, Thakur JS, Jeet G, Chawla S, Jain S, Pal A, Prasad R. Burden and risk factors of dyslipidemia-results from a STEPS survey in Punjab India. Diabetes Metab Syndr. 2017, 11 Suppl 1:S21-7. 10.1016\/j.dsx.2016.08.015","journal-title":"Diabetes Metab Syndr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194819","article-title":"Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: evidences from the National NCDs STEPS survey, 2015","volume":"13","author":"Gebreyes YF","year":"2018","unstructured":"Gebreyes YF, Goshu DY, Geletew TK, et al.. Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: evidences from the National NCDs STEPS survey, 2015. PLoS One. 2018, 13:e0194819. 10.1371\/journal.pone.0194819","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151911","article-title":"Anti-retroviral therapy increases the prevalence of dyslipidemia in South African HIV-infected patients","volume":"11","author":"Dave JA","year":"2016","unstructured":"Dave JA, Levitt NS, Ross IL, Lacerda M, Maartens G, Blom D. Anti-retroviral therapy increases the prevalence of dyslipidemia in South African HIV-infected patients. PLoS One. 2016, 11:e0151911. 10.1371\/journal.pone.0151911","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray CJ","year":"2012","unstructured":"Murray CJ, Vos T, Lozano R, et al.. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012, 380:2197-223. 10.1016\/S0140-6736(12)61689-4","journal-title":"Lancet"},{"key":"ref10","unstructured":"Noncommunicable diseases Madagascar 2018 country profile. (2018). Accessed. May 1, 2024: https:\/\/cdn.who.int\/media\/docs\/default-source\/country-profiles\/ncds\/mdg_en.pdf?sfvrsn=1ae4c02a_36&download=true."},{"key":"ref11","unstructured":"Diabetes Madagascar 2016 country profile. (2016). Accessed. May 1, 2024: https:\/\/cdn.who.int\/media\/docs\/default-source\/country-profiles\/diabetes\/mdg_en.pdf?sfvrsn=7ca54ddb_38&download=true."},{"key":"ref12","article-title":"Adult\u2019s hypertension prevalence and severity in the urban environment of Antananarivo","volume":"1","author":"Rabarijaona LMPH","year":"2009","unstructured":"Rabarijaona LMPH, Rakotomalala DP, Rakotonirina El-CJ, Rakotoarimanana S, Randrianasolo O. Adult\u2019s hypertension prevalence and severity in the urban environment of Antananarivo. Rev Anesth R\u00e9anim Med Urg Toxicol. 2009, 1:24-7.","journal-title":"Rev Anesth R\u00e9anim Med Urg Toxicol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-016-1420-8","article-title":"Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China","volume":"16","author":"Stevens W","year":"2016","unstructured":"Stevens W, Peneva D, Li JZ, Liu LZ, Liu G, Gao R, Lakdawalla DN. Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China. BMC Health Serv Res. 2016, 16:175. 10.1186\/s12913-016-1420-8","journal-title":"BMC Health Serv Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1155-1941(10)51268-X","article-title":"Dyslipidemias and cardiovascular risk: epidemiological data (Article in French)","volume":"7","author":"Ferri\u00e8res J","year":"2010","unstructured":"Ferri\u00e8res J. Dyslipidemias and cardiovascular risk: epidemiological data (Article in French). EMC. 2010, 7:1-8. 10.1016\/S1155-1941(10)51268-X","journal-title":"EMC"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0828-282x(09)70715-9","article-title":"2009 Canadian Cardiovascular Society\/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations","volume":"25","author":"Genest J","year":"2009","unstructured":"Genest J, McPherson R, Frohlich J, et al.. 2009 Canadian Cardiovascular Society\/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol. 2009, 25:567-79. 10.1016\/s0828-282x(09)70715-9","journal-title":"Can J Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016721","article-title":"Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treated","volume":"6","author":"Leren TP","year":"2011","unstructured":"Leren TP, Berge KE. Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treated. PLoS One. 2011, 6:e16721. 10.1371\/journal.pone.0016721","journal-title":"PLoS One"},{"key":"ref17","article-title":"Epidemiological and clinical aspects of dyslipidemia at the medical intensive care units in Antananarivo","volume":"7","author":"Rabenjarison F","year":"2015","unstructured":"Rabenjarison F, Andrianimaro FM, Nanazisoa STC, Rakotoarison RCN, Raveloson NE. Epidemiological and clinical aspects of dyslipidemia at the medical intensive care units in Antananarivo. Rev Anesth R\u00e9anim Med Urg Toxicol. 2015, 7:34-7.","journal-title":"Rev Anesth R\u00e9anim Med Urg Toxicol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ancard.2015.09.045","article-title":"Prevalence of dyslipidemia in the rural population of Gueoul (Senegal) (Article in French)","volume":"65","author":"Thiombiano LP","year":"2016","unstructured":"Thiombiano LP, Mbaye A, Sarr SA, et al.. Prevalence of dyslipidemia in the rural population of Gueoul (Senegal) (Article in French). Ann Cardiol Angeiol (Paris). 2016, 65:77-80. 10.1016\/j.ancard.2015.09.045","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.778891","article-title":"Determinants of dyslipidemia in Africa: a systematic review and meta-analysis","volume":"8","author":"Obsa MS","year":"2021","unstructured":"Obsa MS, Ataro G, Awoke N, et al.. Determinants of dyslipidemia in Africa: a systematic review and meta-analysis. Front Cardiovasc Med. 2021, 8:778891. 10.3389\/fcvm.2021.778891","journal-title":"Front Cardiovasc Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04150-6","article-title":"Prevalence, patterns and determinants of dyslipidaemia among South African adults with comorbidities","volume":"12","author":"Masilela C","year":"2022","unstructured":"Masilela C, Adeniyi OV, Benjeddou M. Prevalence, patterns and determinants of dyslipidaemia among South African adults with comorbidities. Sci Rep. 2022, 12:337. 10.1038\/s41598-021-04150-6","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2020.07.032","article-title":"Epidemiology of dyslipidemia and associated cardiovascular risk factors in northeast China: a cross-sectional study","volume":"30","author":"Xing L","year":"2020","unstructured":"Xing L, Jing L, Tian Y, et al.. Epidemiology of dyslipidemia and associated cardiovascular risk factors in northeast China: a cross-sectional study. Nutr Metab Cardiovasc Dis. 2020, 30:2262-70. 10.1016\/j.numecd.2020.07.032","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250573","article-title":"Prevalence of dyslipidemia and associated risk factors among adult residents of Shenmu City, China","volume":"16","author":"Gao H","year":"2021","unstructured":"Gao H, Wang H, Shan G, Liu R, Chen H, Sun S, Liu Y. Prevalence of dyslipidemia and associated risk factors among adult residents of Shenmu City, China. PLoS One. 2021, 16:e0250573. 10.1371\/journal.pone.0250573","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-017-0591-5","article-title":"Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study","volume":"17","author":"Halcox JP","year":"2017","unstructured":"Halcox JP, Banegas JR, Roy C, et al.. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study. BMC Cardiovasc Disord. 2017, 17:160. 10.1186\/s12872-017-0591-5","journal-title":"BMC Cardiovasc Disord"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S347085","article-title":"Prevalence and patient outcomes of adult primary hypercholesterolemia and dyslipidemia in the UK: longitudinal retrospective study using a primary care dataset from 2009 to 2019","volume":"14","author":"Bilitou A","year":"2022","unstructured":"Bilitou A, Were J, Farrer A, Rabe A, Ming SW, Haq I, Dunton K. Prevalence and patient outcomes of adult primary hypercholesterolemia and dyslipidemia in the UK: longitudinal retrospective study using a primary care dataset from 2009 to 2019. Clinicoecon Outcomes Res. 2022, 14:189-203. 10.2147\/CEOR.S347085","journal-title":"Clinicoecon Outcomes Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.121.007917","article-title":"Race, racism, and cardiovascular health: applying a social determinants of health framework to racial\/ethnic disparities in cardiovascular disease","volume":"15","author":"Javed Z","year":"2022","unstructured":"Javed Z, Haisum Maqsood M, Yahya T, et al.. Race, racism, and cardiovascular health: applying a social determinants of health framework to racial\/ethnic disparities in cardiovascular disease. Circ Cardiovasc Qual Outcomes. 2022, 15:e007917. 10.1161\/CIRCOUTCOMES.121.007917","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023650","article-title":"AHA spotlight on racial and ethnic disparities in cardiovascular disease","volume":"10","author":"Mazimba S","year":"2021","unstructured":"Mazimba S, Peterson PN. AHA spotlight on racial and ethnic disparities in cardiovascular disease. J Am Heart Assoc. 2021, 10:e023650. 10.1161\/JAHA.121.023650","journal-title":"J Am Heart Assoc"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2010.01.001","article-title":"Emerging role of estrogen in the control of cardiometabolic disease","volume":"31","author":"Cignarella A","year":"2010","unstructured":"Cignarella A, Kratz M, Bolego C. Emerging role of estrogen in the control of cardiometabolic disease. Trends Pharmacol Sci. 2010, 31:183-9. 10.1016\/j.tips.2010.01.001","journal-title":"Trends Pharmacol Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280672","article-title":"Prevalence and factors associated with dyslipidemia in Bangladeshi adults","volume":"18","author":"Ali N","year":"2023","unstructured":"Ali N, Samadder M, Kathak RR, Islam F. Prevalence and factors associated with dyslipidemia in Bangladeshi adults. PLoS One. 2023, 18:e0280672. 10.1371\/journal.pone.0280672","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2014.12.001","article-title":"Aging and dyslipidemia: a review of potential mechanisms","volume":"19","author":"Liu HH","year":"2015","unstructured":"Liu HH, Li JJ. Aging and dyslipidemia: a review of potential mechanisms. Ageing Res Rev. 2015, 19:43-52. 10.1016\/j.arr.2014.12.001","journal-title":"Ageing Res Rev"},{"key":"ref30","article-title":"Prevalence of dyslipidaemias in a representative sample of the French population","volume":"98","author":"Ferri\u00e8res J","year":"2005","unstructured":"Ferri\u00e8res J, Ruidavets JB, Perret B, et al.. Prevalence of dyslipidaemias in a representative sample of the French population. Arch Mal Coeur Vaiss. 2005, 98:127-32.","journal-title":"Arch Mal Coeur Vaiss"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1159\/000509570","article-title":"Dyslipidemia and associated risk factors among nigerians with hypertension","volume":"3","author":"Ayoade OG","year":"2020","unstructured":"Ayoade OG, Umoh I, Amadi C. Dyslipidemia and associated risk factors among nigerians with hypertension. Dubai Med J. 2020, 3:155-61. 10.1159\/000509570","journal-title":"Dubai Med J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243103","article-title":"Prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City, Northern Ethiopia","volume":"16","author":"Gebreegziabiher G","year":"2021","unstructured":"Gebreegziabiher G, Belachew T, Mehari K, Tamiru D. Prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City, Northern Ethiopia. PLoS One. 2021, 16:e0243103. 10.1371\/journal.pone.0243103","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-002640","article-title":"Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries","volume":"5","author":"Chow CK","year":"2020","unstructured":"Chow CK, Nguyen TN, Marschner S, et al.. Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries. BMJ Glob Health. 2020, 5:002640. 10.1136\/bmjgh-2020-002640","journal-title":"BMJ Glob Health"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.4700","article-title":"National trends in statin use and expenditures in the US adult population from 2002 to 2013: Insights from the medical expenditure panel survey","volume":"2","author":"Salami JA","year":"2017","unstructured":"Salami JA, Warraich H, Valero-Elizondo J, et al.. National trends in statin use and expenditures in the US adult population from 2002 to 2013: Insights from the medical expenditure panel survey. JAMA Cardiol. 2017, 2:56-65. 10.1001\/jamacardio.2016.4700","journal-title":"JAMA Cardiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/2325957415614642","article-title":"Lipid profile in HIV-infected patients using first-line antiretroviral drugs","volume":"15","author":"Ombeni W","year":"2016","unstructured":"Ombeni W, Kamuhabwa AR. Lipid profile in HIV-infected patients using first-line antiretroviral drugs. J Int Assoc Provid AIDS Care. 2016, 15:164-71. 10.1177\/2325957415614642","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-017-0594-3","article-title":"The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk","volume":"16","author":"Femlak M","year":"2017","unstructured":"Femlak M, Gluba-Brz\u00f3zka A, Cia\u0142kowska-Rysz A, Rysz J. The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk. Lipids Health Dis. 2017, 16:207. 10.1186\/s12944-017-0594-3","journal-title":"Lipids Health Dis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/nu5041218","article-title":"Dyslipidemia in obesity: mechanisms and potential targets","volume":"5","author":"Klop B","year":"2013","unstructured":"Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013, 5:1218-40. 10.3390\/nu5041218","journal-title":"Nutrients"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/315701-prevalence-and-characteristics-of-dyslipidemia-in-a-hospital-in-madagascar","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T11:09:48Z","timestamp":1731323388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/315701-prevalence-and-characteristics-of-dyslipidemia-in-a-hospital-in-madagascar"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.73424","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,11]]}}}